Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

PR Newswire

Financial release accessible online

BOSTON, Nov. 2, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2024, which ended September 30, 2023, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 2, 2023. The conference call and webcast can be accessed with the following information:

In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.  

Direct link to 2Q FY24 Earnings Release:
https://haemonetics.gcs-web.com/static-files/59b19d68-753c-4e39-a6c5-e2ea261b0658

A replay of the conference call and webcast will be available for one year beginning on November 2, 2023, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:             


Olga Guyette, Sr. Director-Investor Relations & Treasury  

David Trenk, Manager-Investor Relations

(781) 356-9763                                                                       

(203) 733-4987

[email protected]                                           

[email protected]                                                                               

 

Media Contact:          


Josh Gitelson, Director-Global Communications


(781) 356-9776


[email protected] 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2024-earnings-release-available-on-investor-relations-website-301975313.html

SOURCE Haemonetics Corporation

Copyright CNW Group 2023